May Press      ||      Home Page

 


Chairman Filner, ask Secretary of VA to restart NVVLS study

NEWS FROM...
CHAIRMAN BOB FILNER
HOUSE COMMITTEE ON VETERANS' AFFAIRS

FOR IMMEDIATE RELEASE
Contact Kristal DeKleer at (202) 225-9756

http://veterans.house.gov


Congress, Vietnam Veterans Dissatisfied With VA's Unreasonable Allocation of Service-Connected Benefits


Washington, D.C.
On Wednesday, May 5, 2010, House Committee on Veterans' Affairs Chairman Bob Filner (D-CA)
conducted a hearing to examine the health effects that veterans sustained during the War in Vietnam as a result
of being exposed to the toxic dioxin-based concoctions that we now generally refer to as Agent Orange and discuss related legislation.

The Committee will also follow-up on the outstanding directive to the Department of Veterans Affairs (VA)
to conduct the National Vietnam Veterans Longitudinal Study (NVVLS).

In 1984, Congress required the VA to conduct the National Vietnam Veterans Readjustment Study (NVVRS),
a landmark analysis on the prevalence of psychosocial and physical health problems among Vietnam veterans.

In 2000, Congress mandated that the VA conduct a follow-up study, the NVVLS, to reassess the same cohort of veterans and better understand the prevalence of post-traumatic stress disorder (PTSD), cardiovascular disease, general psychiatric syndromes, as well as their health care utilization patterns. VA Secretary Eric Shinseki decided to restart the NVVLS in September 2009, although it seems the project has stalled due to cost concerns and perceived difficulty of administration.

"It is time for VA to return to the forefront of research and public policy - which is why I asked Secretary Shinseki to restart the study," said Chairman Filner.

"In order to better understand the consequences of war, we must increase our knowledge of the Vietnam generation
so we can improve care for every American veteran.

Findings from the study will inform policy regarding health services, rehabilitation, and compensation - and there is just too much that we still don't know.

I do not understand this level of bureaucratic procrastination in response to collecting data that would inform health providers and lead to effective treatments for affected veterans."

Some Vietnam veterans returned home only to experience serious illnesses as a result of their exposure to Agent Orange.

Dissatisfied with VA's regulatory interpretation of Congress' several legislative efforts to provide these veterans with care
and benefits for their disabilities, Congress enacted the Agent Orange Act in 1991, which established for the first time a presumption of service-connection for diseases associated with herbicide exposure.

Currently there are 14 recognized presumptive service-connected conditions related to herbicide exposure, including the newly added B cell leukemias, Parkinson's disease, and ischemic heart disease.

VA published proposed regulations on these three new presumptions conditions on March 25, 2010.

The overwhelming majority of stakeholders, including DoD, Institute of Medicine, Congress, the Court of Appeals
for Veterans Claims, veteran service organizations, and many researchers, conclude that a veteran's exposure to
Agent Orange cannot be properly determined solely based on troop movement.

However, currently in its regulations and internal procedural manuals, VA requires a "foot on land" occurrence in Vietnam
in order to award service-connected disability compensation, which determines that certain veterans suffering from
exposure to Agent Orange are not eligible for VA benefits and related health care.

According to VA, this reversal had the effect of excluding more than 800,000 combat Vietnam veterans from presumptive service-connection. Affected veterans have been contesting this regulation since its inception as it represents an abrupt reversal of VA's previous regulations wherein these veterans were eligible for compensation and also creates an artificial and unprecedented distinction between combat veterans.

Chairman Filner introduced the Agent Orange Equity Act of 2009 (H.R. 2254) to provide these veterans with benefits based on their exposure to Agent Orange regardless of arbitrary geographic line drawing that imposed by the VA.

If enacted, this bill would clarify service in Vietnam to include those who served in the inland waterways, the
waters offshore, air space above Vietnam, and on Johnston Island where disposal of Agent Orange occurred after the war.

Under H.R. 2254, any veteran awarded the Vietnam Service Medal or the Vietnam Campaign Medal would be entitled to the benefit of Agent Orange presumptions just like other Vietnam era combat veterans.

The bipartisan bill has 256 cosponsors.

Filner concluded: "I am convinced that Vietnam veterans are suffering and dying while VA dithers and vacillates.

VA should be ashamed of its illogical 'foot on land requirement' regulation that unfairly keeps the Blue Water class of veterans from receiving the benefits and treatment that they have earned and deserve.

I strongly urge VA to reverse this policy consistent with the Institute of Medicine's 2008 Update recommendations.

VA also should be ashamed of the fact that it has not begun, yet alone completed, the decade-long overdue NVVLS study.

We need this information to take better care of these veterans and VA needs to do everything in its power to make sure
that it finally gets done.

These heroes served bravely and should not have to plead with their government to receive the care and benefits they
were promised and that Congress mandated.

Vietnam veterans are not looking for sympathy. They are looking for our grateful Nation to fulfill its promises."

WITNESS LIST

Panel 1

Richard A. Fenske, Ph.D., M.P.H., Professor and Acting Chair of Environmental and Occupational Health Sciences,
School of Public Health and Community Medicine, University of Washington, Seattle, and Chair, Committee on the
Review of the Health Effects in Vietnam Veterans of Exposure to Herbicides (7th Biennial Update),
Board on the Health of Select Populations, The Institute of Medicine, The National Academies

Charles R. Marmar, M.D., Chair, Department of Psychiatry, NYU Langone School of Medicine
Randall B. Williamson, Director, Health Care, U.S. Government Accountability Office

Panel 2

Richard F. "Rick" Weidman, Executive Director for Policy and Government Affairs, Vietnam Veterans of America

Joseph L. Wilson, Deputy Director, Veterans Affairs and Rehabilitation Commission, The American Legion
Commander John B. Wells, USN (Ret.), Cofounder and Trustee, Veterans Association of Sailors of the Vietnam War
John Paul Rossie, Executive Director, Blue Water Navy Vietnam Veterans Association
Vivianne Cisneros Wersel, Au.D., Chair, Government Relations Committee, Gold Star Wives of America

Panel 3

Joel Kupersmith, M.D., Chief Research and Development Officer, Veterans Health Administration,
U.S. Department of Veterans Affairs
Accompanied by
Victoria Anne Cassano, M.D., M.P.H., F.A.C.P.M., Capt. MC USN (Ret.),
Director, Radiation and Physical Exposures and Acting Director, Environmental Agents Service, Veterans Health Administration, U.S. Department of Veterans Affairs

###
Prepared testimony and a link to the webcast of the hearing are available on the internet at this link: http://veterans.house.gov/hearings/hearing.aspx?newsid=571